PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12695351-4	2003	In contrast, treatment with 0.1 microM DEX enhanced CYP2B6 induction by different pregnane X receptor (PXR) activators, including rifampin, phenytoin, clotrimazole, and phenobarbital.	Dexamethasone	39-42	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	52-58	
16135659-7	2005	All 23 single assays were validated by assessing the effects (induction or repression) of known inducers (ethanol, 3-methylcholanthrene, rifampicin, dexamethasone, phenobarbital) on P450 expression in human primary hepatocytes.	Dexamethasone	149-162	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	182-186	
20307138-6	2010	Female livers and livers exposed to inducers (phenobarbital and/or dexamethasone) were associated with higher CYP2B6.	Dexamethasone	67-80	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	110-116	
25409894-0	2015	Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.	Dexamethasone	109-122	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	20-26	
12485953-4	2003	Microsomes prepared from dexamethasone-pretreated rats metabolized clopidogrel at a rate of 3.8 nmol min(-1) nmol of p450(-1), which is 65 and 1270% faster than the rate of metabolism by microsomes from control and beta-napthoflavone-treated rats, respectively.	Dexamethasone	25-38	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	117-121	
12065440-1	2002	The purpose of this study was to characterize the concentration-response effects of cyclophosphamide (CPA) with and without dexamethasone (DEX; 10 microM) on the expression of CYP3A4 and CYP2B6 in cultured human hepatocytes at concentrations representative of standard- and high-dose CPA therapy (25 to 750 microM).	Dexamethasone	124-137	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	187-193	
12065440-1	2002	The purpose of this study was to characterize the concentration-response effects of cyclophosphamide (CPA) with and without dexamethasone (DEX; 10 microM) on the expression of CYP3A4 and CYP2B6 in cultured human hepatocytes at concentrations representative of standard- and high-dose CPA therapy (25 to 750 microM).	Dexamethasone	139-142	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	187-193	
12065440-3	2002	The inductive effect of CPA alone and in combination with DEX was greater in magnitude for CYP2B6 compared with CYP3A4.	Dexamethasone	58-61	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	91-97	
11093784-4	2000	We show that submicromolar concentrations of dexamethasone enhance phenobarbital-mediated induction of CYP3A4, CYP2B6, and CYP2C8 mRNA in cultured human hepatocytes.	Dexamethasone	45-58	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	111-117	
8055971-10	1994	Liver microsomes from rats pretreated with dexamethasone, a specific inducer of P450 3A, were found to be particularly active for the hydroxylation of bromocriptine, which occurs at the level of its tripeptide moiety.	Dexamethasone	43-56	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	80-84	
3654968-2	1987	In rat enterocytes, we found two dexamethasone-inducible proteins related to the steroid-inducible liver cytochromes P-450.	Dexamethasone	33-46	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	117-122	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	53-66	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	20-26	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	53-66	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	92-98	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	53-66	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	92-98	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	68-71	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	20-26	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	68-71	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	92-98	
25409894-2	2015	The inducibility of CYP2B6 by phenobarbital (PB) and dexamethasone (DEX), known inducers of CYP2B6 in human liver, was examined in the TG mice, as well as in TG/Cyp2abfgs-null (or "CYP2B6-humanized") mice.	Dexamethasone	68-71	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	92-98	
25409894-3	2015	Hepatic expression of CYP2B6 mRNA and protein was greatly induced by PB or DEX treatment in both TG and TG/Cyp2abfgs-null mice.	Dexamethasone	75-78	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	22-28